Check out Dr. Paolo Tarantino Paolo Tarantino Dana-Farber’s Breast Oncology Center discussing top 5 takeaways from #SABCS23 including KATHERINE & INAVO120

#bcsm #HER2 #TNBC #BreastCancer
full📽️on #VuMedi
👇
bit.ly/TOP5SABCS23

Check out Dr. Sara Tolaney Sara Tolaney Dana-Farber’s Breast Oncology Center & Dr. Hope Rugo Hope Rugo UCSF Helen Diller Family Comprehensive Cancer Ctr discussing #SABCS23 highlights: 'What Is the Appropriate 1L Therapy for ER+ mBC?'

Full📽️on #VuMedi
👇
bit.ly/1LermBC

#bcsm #breastcancer #mBC #TNBC

#SABCS23 Highlights w/ Hope Rugo on HR+ #breastcancer

- #NATALEE
- #MONARCH3
- #INAVO120
- #TB01

Full discussion:
- oncbrothers.com/sabcs23-rugo
- targetedonc.com/data-dialogue-…
- Also on “Oncology Brothers” podcast

#MedTwitter #OncTwitter #bcsm SABCS Targeted Oncology

#SABCS23 Highlights w/ Daniel Stover, MD, FASCO on HER2+ #breastcancer

- #APHINITY
- #KATHERINE
- #HER2Climb02

Full discussion:
- OncBrothers.com/sabcs23-stover
- targetedonc.com/data-dialogue-…
- Also on the “Oncology Brothers” podcast

#MedTwitter #OncTwitter #bcsm SABCS Targeted Oncology

Dr. Mariana Chavez-MacGregor’s overview of the year in review for metastatic breast cancer at #SABCS23 was one of the best overviews I have seen. I know I am biased, but it was truly outstanding. MD Anderson Cancer Center

The NATALEE phase 3 trial of adjuvant ribo for stage II-III HR+ BC is published in NEJM. With 28 months f-up, adding ribo for 3y to adjuvant AI led to a significant benefit in 3y iDFS (Δ≃3%). Updated results at SABCS23 were consistent with this analysis. nejm.org/doi/full/10.10…

A week ago,I reunited w/ Tatiana Prowell, MD at #SABCS23 , marking our first meeting since SABCS in 2019. As my initial contact w/a GRASP scientist, she guided me & other advocates through the world of scientific posters. BTW virtual GRASP at #SABCS23 starts today!

There was a buzz in San Antonio about research and results from INAVO120.

Watch as Kim MacDonald 🌻 and BCC Chairperson Shaniah Leduc, give an overview of the study and what it means for the future of care.

We look forward to sharing more on this soon!
Roche SABCS #SABCS23

ICYMI: At #SABCS23 Dana-Farber's Heather Parsons (@hthrparsons) presented a new study showing liquid biopsy could reliably determine whether a patient's breast cancer is HER2-positive or -negative.

Here the updated analysis of NATALEE presented at #SABCS23 , with longer median follow up (33 months) and 78% of the patients that had completed (43%) or discontinued (35%) treatment with adjuvant ribociclib.

Nice summary of the best of SABCS #SABCS23 by Shelley Hwang! #ASBrS24 ASBrS

18th Best of #SABCS23 in #Riyadh #SaudiArabia Excellent conference reviews and discussions 👍👍 Thanks to Dr Omalkhair Abulkhair SABCS #breastcancer

📺 Watch it now! Our 2023 SABCS recap webinar is now available on demand, only in the Outcomes4Me app: bit.ly/47vxPyL
#SABCS23 #breastcancerresearch

Additionally, in our🇧🇷 #GBECAM cohort (HR+ eBC pts who received Oncotype DX) presented at #SABCS23 , 4% of pts were eligible for adj. abemaciclib and 21% for ribociclib.

‼️Among these pts, more than 50% did not meet genomic criteria for chemotherapy.
OncoAlert SABCS

Dr. Bidard highlights technical aspects of ESR1 mutation detection

#SABCS23

Dr Jane Lowe Meisel, MD Winship Cancer Institute of Emory University gave a comprehensive review of the management of #HER2 #breastcancer this am at The James #SABCS23 Update. Lots of great questions posed for future research

ER+ breast cancer updates from SABCS23. Glad to be part of a great symposium today #WAHO SABCS MCW Cancer Center Froedtert

Dr. Bidard walking us through #PADA1 and all the correlative science in the best way I have heard to date! 👏

Mutant allele fraction linked to outcome...not just a yes/no question

#SABCS23

Thrilled to have attended SABCS #SABCS23 this year!! My brain is buzzing with excitement from this incredible learning opportunity!! Massive thank you to #UQCCR ECR Enabler Scheme and Sunil Lakhani Molecular Breast Pathology Lab for their generous sponsorship!!
UQ Medicine UQ News

Updates and #sabcs23 … nohalfmeasures.blog/2023/12/11/cli… #bcsm